Regulus Therapeutics
RGLS
#8605
Rank
ยฃ0.10 B
Marketcap
ยฃ1.55
Share price
6.19%
Change (1 day)
-17.35%
Change (1 year)

Revenue for Regulus Therapeutics (RGLS)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Regulus Therapeutics from 2012 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A
2022 N/A
2021 N/A-100%
2020 ยฃ7.34 M40.9%
2019 ยฃ5.21 M9085.36%
2018 ยฃ0.05 M6.47%
2017 ยฃ0.05 M-94.49%
2016 ยฃ0.96 M-93.09%
2015 ยฃ14 M184.38%
2014 ยฃ4.92 M-58.48%
2013 ยฃ11.86 M50.98%
2012 ยฃ7.85 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ30.29 BN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ36.15 BN/A๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ7.29 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ40.76 BN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ1.69 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ43.57 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ36.41 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.14 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA